Alpha Brain Supplements Provide No Brain-Enhancing Benefits, Class Action Says
Martin v. Onnit Labs, Inc.
Filed: May 16, 2023 ◆§ 2:23-cv-03737
The makers of the Alpha Brain dietary supplement face a class action that alleges the product does not support memory, focus or cognitive processing speed as advertised.
The makers of the Alpha Brain dietary supplement face a proposed class action that alleges the product does not support memory, focus or cognitive processing speed as advertised.
Want to stay in the loop on class actions that matter to you? Sign up for ClassAction.org’s free weekly newsletter here.
According to the six-page lawsuit, the claim from defendant Onnit Labs that its purportedly brain-boosting supplement offers the “ultimate way to get ‘in the zone’” has been “proven false by the overwhelming weight of scientific evidence.”
In fact, the case contends that several studies have shown that the ingredients in Alpha Brain fail to provide any of the promised cognitive effects.
The plaintiff, a California resident who works as a “tester” to ensure that companies adhere to state law, says they bought Alpha Brain to obtain its advertised benefits yet did not experience any of the product’s touted brain-enhancing benefits.
“By making demonstrably false claims that its product provides memory benefits that it does not and cannot provide, Defendant has illegally collected millions of dollars from unsuspecting consumers,” the suit stresses.
The lawsuit looks to represent anyone within the United States who purchased Alpha Brain supplements for personal use within the past six months.
Get class action lawsuit news sent to your inbox – sign up for ClassAction.org’s free weekly newsletter here.
Camp Lejeune
Camp Lejeune residents now have the opportunity to claim compensation for harm suffered from contaminated water.
Read more here: Camp Lejeune Lawsuit Claims
Stay Current
Sign Up For
Our Newsletter
New cases and investigations, settlement deadlines, and news straight to your inbox.
Before commenting, please review our comment policy.